Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.
- Conditions
- MelanomaNeoplasm Metastasis
- Registration Number
- NCT00057616
- Lead Sponsor
- Celgene
- Brief Summary
Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Subjects are treated in repeating 4 week cycles.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 274
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (49)
Royal Newcastle Hospital
🇦🇺Newcastle, New South Wales, Australia
Westmead Hospital
🇦🇺Westmead, New South Wales, Australia
Royal Hobart Hospital
🇦🇺Hobart, Tasmania, Australia
Princess Alexandra Hospital
🇦🇺Woolloongabba, Queensland, Australia
Mount HospitalOncology
🇦🇺Perth, Western Australia, Australia
Dermatologie Klinik der Ruhr Universitat Bochum- St. Joseph's Hospital
🇩🇪Bochum, Germany
Klinick fur Dermatologie
🇩🇪Berlin, Germany
Universitatsklinikum Freiburg
🇩🇪Freiburg, Germany
Universitatsklinik Eppendorf
🇩🇪Hamburg, Germany
Klinick fur Dermatolgie
🇩🇪Bonn, Germany
Klinik fur DermatologieVenerologie und Allergologie
🇩🇪Mannheim, Germany
Kinkum der Christian-Albrecht-Universitat KielDepartment of Dermatologie
🇩🇪Kiel, Germany
Latvian Onkology Centre
🇱🇻Riga, Latvia
Panorama Medi-Clinic / Panorama Oncology Unit
🇿🇦Cape Town, South Africa
Wilgers Hospital / Wilgers Oncology Centre
🇿🇦Hatfield, Pretoria, South Africa
Addington Hospital
🇿🇦Durban, South Africa
St. Georges Hospital
🇿🇦Port Elizabeth, South Africa
Sandton Oncology Centre
🇿🇦Morningside, Johannesburg, South Africa
Durban Oncology Centre
🇿🇦Westridge, Durban, South Africa
Little Company of Mary / Mary Potter Oncology Centre
🇿🇦Pretoria, South Africa
Pretoria Academic Hospital / Department Medical Oncology
🇿🇦Pretoria, South Africa
Dnipropetrovsk State Medical Academy
🇺🇦Dnipropetrovsk, Ukraine
Kiev City Oncology Hospital
🇺🇦Kiev, Ukraine
Scientific Research Institute of OncologySoft Tissue Department
🇺🇦Kiev, Ukraine
Kharkov Postgraduate Medical Academy, Kharkov Regional Clinical Oncology Center
🇺🇦Kharkov, Ukraine
Odessa Regional Oncology DispensaryChemotherapy Dept
🇺🇦Odessa, Ukraine
Lviv State Medical University Regional Oncology Centre
🇺🇦Lviv, Ukraine
Cancer Centre
🇬🇧Egbaston, Birmingham, United Kingdom
Beatson Oncology CentreWestern InfirmaryOncology
🇬🇧Glasgow, United Kingdom
Cancer Research BldgDivsion of Cancer Medicine Research
🇬🇧Leeds, United Kingdom
Roayl Free Hospital
🇬🇧London, United Kingdom
St. George's Hospital
🇬🇧London, United Kingdom
Royal Marsden Hospital Department of Oncology
🇬🇧London, United Kingdom
Christies Hospital
🇬🇧Withington, Manchester, United Kingdom
Sir Charles Gairdner Hospital
🇦🇺Nedlands, Western Australia, Australia
Royal Prince Alfred Hospital
🇦🇺Camperdown, New South Wales, Australia
Sydney Cancer Centre
🇦🇺Camperdown, New South Wales, Australia
Roayl Brisbane Hospital
🇦🇺Herston, Queensland, Australia
Royal Adelaide Hospital
🇦🇺Adelaide, South Australia, Australia
Royal Marsden Hospital
🇬🇧London, United Kingdom
Newcastle GeneralOncology
🇬🇧Newcastle, United Kingdom
Tartu University Clinics Onkology & Haematology Clinic
🇪🇪Tartu, Estonia
Daniel DenHoed Kliniek
🇳🇱Rotterdam, Netherlands
Vilnius University Onkology Institute
🇱🇹Vilnius, Lithuania
Cabrini Hospital
🇦🇺Malvern, Victoria, Australia
North-Estonian Regional Hospital
🇪🇪Tallinn, Estonia
Klaipeda Hospital
🇱🇹Klaipeda, Lithuania
The Canberra Hospital
🇦🇺Garran, Australian Capital Territory, Australia
Uzhgorod Regional Oncology Diepensary
🇺🇦Uzhgorod, Ukraine